Related Experiment Video
Updated: Aug 5, 2026

Hypothalamic Kisspeptin Neurons as a Target for Whole-Cell Patch-Clamp Recordings
Published on: March 17, 2023
Kisspeptin Signaling Suppresses HRasG12V-induced Tumor Growth and Metastasis by Inhibiting SP1-dependent N-cadherin
Hyun-Ha Hwang1, Sung-Gook Cho2
1Department of Science in Korean Medicine, Graduate School, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.
Background/Aim:
Kisspeptin signaling is recognized as a metastasis-suppressive pathway, but its role in oncogenic HRAS-driven tumor progression remains incompletely understood. This study investigated whether kisspeptin signaling suppresses HRASG12V-induced tumorigenic and metastatic phenotypes in NIH3T3 cells and examined the involvement of SP1-dependent transcription of N-cadherin.
Materials And Methods:
NIH3T3 cells expressing HRASG12V, KISS1, and KISS1R were analyzed for proliferation, migration, invasion, luciferase reporter activity, anchorage-independent growth, and in vivo tumor growth and pulmonary metastasis. N-cadherin expression was examined by RT-PCR and immunoblotting. N-cadherin promoter regulation was analyzed using luciferase reporter and chromatin immunoprecipitation assays.
Results:
Kisspeptin signaling reduced NIH3T3 cell proliferation, migration, and invasion and activated SRF reporter activity through the KISS1R-Gaq/11-p63RhoGEF-RhoA pathway. In HRASG12V-expressing NIH3T3 cells, KISS1 reduced N-cadherin expression and suppressed anchorage-independent colony formation. HRASG12V increased N-cadherin promoter activity, whereas KISS1 reduced both basal and HRASG12V-induced promoter activation. Deletion of the SP1-responsive region abolished these effects, and chromatin immunoprecipitation showed reduced SP1 binding to the N-cadherin promoter. In vivo, KISS1 suppressed HRASG12V-induced tumor growth and pulmonary metastasis, and N-cadherin expression reversed these effects.
Conclusion:
Kisspeptin signaling suppresses HRASG12V-induced tumor growth and metastasis in NIH3T3 cells by inhibiting SP1-dependent transcription of N-cadherin.
Insights
Kisspeptin signaling suppresses HRAS-driven tumor growth and metastasis. This pathway inhibits N-cadherin transcription, a key factor in tumor progression.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Kisspeptin signaling is a known metastasis suppressor.
- Its role in HRAS-driven cancers is not fully understood.
- HRAS mutations drive tumor progression and metastasis.
Purpose of the Study:
- Investigate kisspeptin's effect on HRASG12V-induced tumors.
- Determine kisspeptin's impact on N-cadherin transcription.
- Elucidate the role of SP1 in this pathway.
Main Methods:
- NIH3T3 cells expressing HRASG12V, KISS1, and KISS1R were used.
- Assays included proliferation, migration, invasion, and anchorage-independent growth.
- N-cadherin expression and promoter activity were analyzed via RT-PCR, immunoblotting, luciferase reporters, and ChIP.
Main Results:
- Kisspeptin signaling reduced proliferation, migration, and invasion.
- Kisspeptin suppressed HRASG12V-induced N-cadherin expression and colony formation.
- Kisspeptin inhibited SP1-dependent N-cadherin transcription, reducing tumor growth and metastasis.
Conclusions:
- Kisspeptin signaling suppresses HRASG12V-induced tumor growth and metastasis.
- This suppression occurs via inhibition of SP1-dependent N-cadherin transcription.
- N-cadherin is a critical mediator in kisspeptin's anti-metastatic effects.
More Related Videos
12:49Mutagenesis and Analysis of Genetic Mutations in the GC-rich KISS1 Receptor Sequence Identified in Humans with Reproductive Disorders
Published on: September 4, 2011
07:26Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
Published on: January 31, 2025
Related Concept Videos
The JAK-STAT Signaling Pathway
The Ras Gene
Ras is a superfamily...
Hedgehog Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation